Opertech - header-01

LGM Pharma is a proud supplier of API’s to Opertech Bio for the development of their innovative High-Throughput Taste Evaluation System - the TāStation® system.

Faster Greater FewerA Pioneering Approach to Taste Testing Opertech Bio is a service-based business offering its customers a pioneering approach to measuring taste, a multi-billion dollar market covering the food and beverage, flavor ingredients, pet food, and pharmaceutical industries.

Opertech Bio’s TāStation® technologyOpertech Bio’s TāStation® (Taste+Station) technology is the first automated high throughput system for rapid characterization of taste sensory properties. The TāStation® system dramatically reduces the reliance on traditional taste panel testing and the associated expenditure of resources in time and costs.

TāStation® is quite different than traditional taste testing methods and offers many advantages that promise to enhance the productivity of sensory testing and accelerate product development decision making. In particular, TāStation® is ideally suited to help OTC and Rx companies evaluate the taste of medicines in an effort to mitigate the bitterness of their products.

This is because TāStation® generates tremendous amounts of data using very tiny amounts of API thereby overcoming the issue of a taste panelist ingesting too much drug. The Company claims that the capability to test with this minimal level of pharmaceutical exposure cannot be accomplished by any other method or service providers.

TāStation® is also ideal for the evaluation of new sweeteners, taste enhancers or bitter blockers. It also has broad application in flavor optimization, providing a combinatorial strategy for developing the best tasting ingredient mixtures. TāStation® continues to gain acceptance throughout the industry and the Company’s clientele include several of the world’s largest and best known food and beverage, pharmaceutical and consumer healthcare companies

Subject responds on the TāStation® touch-sensitive monitor

The TāStation® system includes a portable work station with an automated system for delivering small samples in rapid succession to a subject. An individual is trained through an interactive algorithm, which operates like a game, to make responses on a touch sensitive monitor that are dependent on his ability to detect and distinguish taste stimuli.

Responses are rewarded with an incremental point system that incentivizes sensory acuity. The subjects are focused on the game and may not even be aware that their taste sensitivities and preferences are being recorded.

Subject self administersMore data means greater informative power. The comparatively large data sets that are rapidly generated by the TāStation® system are amenable to sophisticated computational and analytic tools not practical for the limited information from traditional taste assessment.

Among the many advantages that result are vastly reduced errors, greater precision in detecting taste effects, improved consistency and predictive value of test outcomes, and the ability to more quickly and broadly test across a diversity of human subjects.

For more information regarding Opertech Bio and the TāStation® technology, please visit their website at www.opertechbio.com or contact our team at LGM to discuss your API requirements.

Other Featured Clients in Action

Orbis Biosciences, Inc. provides controlled-release delivery technologies to create revolutionary pharmaceutical products that are safer and more effective than existing treatment options. Learn More >


Orbis Biosciences, Inc. provides controlled-release delivery technologies to create revolutionary pharmaceutical products that are safer and more effective than existing treatment options. Learn More >

Illustris is a clinical-stage biodevelopment company whose objective is to reduce society’s exposure to potentially harmful active agents by utilizing our novel permeation technology to deliver active agents through tissue structures more efficiently. Learn More >

Illustris is a clinical-stage biodevelopment company whose objective is to reduce society’s exposure to potentially harmful active agents by utilizing our novel permeation technology to deliver active agents through tissue structures more efficiently. Learn More >

This website uses cookies. By using our site, you agree to our terms of service